- collapse A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients.
- collapse Observational retrospective Study to Describe the Management of Advanced or Metastatic EGFR Mutated Non-small Cell Lung Cancer Patients in Spain.
- collapse A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults
- collapse A diagnostic study to determine the prevalence of EGFR mutations in Asian and Russian patients with advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma histologies
- collapse Tolerability,Pharmacokinetics&Preliminary Antitumour Activity of Ascending Doses of AZD9291 in Patients With Advanced Non Small Cell LungCancer Who Have Progressed Following Prior Therapy With an Epidermal Growth FactorReceptorTyrosineKinaseInhibatoragent
- collapse A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (ACT-FASTER:)
- collapse D1691C00007
- collapse D0490C00005
- collapse A multi-center, randomised, double-blind, parallel-group phase III study to assess high dose esomeprazole Na i.v. treatment (bolus infusion of 80 mg followed by a continuous infusion of 8 mg per hour administered for 72 hours) for prevention of rebleeding.
- collapse Oxis 9mcg Turbuhaler Clinical Experience Investigation
